Alcista
$24.00
Precio del escenario
$11.030
-0.340 (-3.08%)Al cierre
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Stocks Investors Should Consider Selling Now

Cellebrite DI: A Leader in Digital Forensics

Cellebrite Announces 2027 JUSTYS Awards Ceremony

Cellebrite Launches JUSTYS Awards to Honor Digital Investigations

Cellebrite Unveils 2027 JUSTYS Awards with New Categories
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.
Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.